
LoewsL
Quality and valuation
How Loews compares with other financials stocks. A description, not a recommendation.
BRK.B
JPM
V
MA
BAC
MS
LLoews and 6 multi-line insurance peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.
A weaker business than most financials companies, priced about in line with them.
Loews trades at 13.6 times its last 12 months of earnings, against a median of 14.6x for the 84 financials stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.
- Revenue grew slower than the sector median: +3.5% vs +10.2%
- Turns less of its sales into cash: 9.4% vs 20.3%
- Keeps less of its revenue as profit (net margin): 9.0% vs 20.7%
Financials
From Loews's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.
| Last 12 months | L | Sector median |
|---|---|---|
| Revenue growth | +3.5% | +10.2% |
| Free cash flow margin | 9.4% | 20.3% |
| Price to earnings | 13.6x | 14.6x |
Stories on Loews
We haven't written about Loews yet. Follow it, and its first story will show under My stocks on the front page.
Similar companies
Multi-line Insurance, by market value.
| Company | Price | Today |
|---|---|---|
BRK.BBerkshire Hathaway | $542.49 | +0.10% |
JPMJPMorgan Chase | $337.04 | −1.90% |
VVisa | $413.59 | +0.74% |
MAMastercard | $638.01 | +0.36% |
BACBank of America | $50.01 | −2.21% |
HSBCHSBC | $85.42 | −1.36% |
MSMorgan Stanley | $184.30 | −2.41% |
GSGoldman Sachs | $894.55 | −3.58% |

